De Paoli M - Search Results

1

Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis.

Farinati F, Herszényi L, Plebani M, Carraro P, De Paoli M, Cardin R, Roveroni G, Rugge M, Nitti D, Grigioni WF, D'Errico A, Naccarato R. Farinati F, et al. Among authors: de paoli m. Carcinogenesis. 1996 Dec;17(12):2581-7. doi: 10.1093/carcin/17.12.2581. Carcinogenesis. 1996. PMID: 9006092

2

The role of urokinase-type plasminogen activator and its inhibitor PAI-1 in gastric cancer.

Herszényi L, Plebani M, Cardin R, Carraro P, De Paoli M, Roveroni G, Naccarato R, Farinati F. Herszényi L, et al. Among authors: de paoli m. Acta Physiol Hung. 1995;83(3):213-21. Acta Physiol Hung. 1995. PMID: 8852646 Clinical Trial.

3

Impaired fibrinolysis and increased protease levels in gastric and duodenal mucosa of patients with active duodenal ulcer.

Herszènyi L, Plebani M, Carraro P, De Paoli M, Cardin R, Di Mario F, Kusstatscher S, Naccarato R, Farinati F. Herszènyi L, et al. Among authors: de paoli m. Am J Gastroenterol. 1997 May;92(5):843-7. Am J Gastroenterol. 1997. PMID: 9149198

4

Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role.

Plebani M, Herszènyi L, Carraro P, De Paoli M, Roveroni G, Cardin R, Tulassay Z, Naccarato R, Farinati F. Plebani M, et al. Among authors: de paoli m. Clin Exp Metastasis. 1997 Jul;15(4):418-25. doi: 10.1023/a:1018454305889. Clin Exp Metastasis. 1997. PMID: 9219730 Clinical Trial.

5

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.

Herszényi L, Farinati F, Cardin R, István G, Molnár LD, Hritz I, De Paoli M, Plebani M, Tulassay Z. Herszényi L, et al. Among authors: de paoli m. BMC Cancer. 2008 Jul 10;8:194. doi: 10.1186/1471-2407-8-194. BMC Cancer. 2008. PMID: 18616803 Free PMC article.

6

Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers.

Herszényi L, István G, Cardin R, De Paoli M, Plebani M, Tulassay Z, Farinati F. Herszényi L, et al. Among authors: de paoli m. Eur J Cancer Prev. 2008 Oct;17(5):438-45. doi: 10.1097/CEJ.0b013e328305a130. Eur J Cancer Prev. 2008. PMID: 18714186

7

Cytokines may influence tumor growth and spread. An in vitro study in two human cancer cell lines.

Panozzo MP, Basso D, De Paoli M, Carraro P, Burighel D, Plebani M. Panozzo MP, et al. Among authors: de paoli m. Int J Clin Lab Res. 1996;26(4):240-4. doi: 10.1007/BF02602956. Int J Clin Lab Res. 1996. PMID: 9007614

8

[Prognostic role of cisteine and serin proteases in gastriC cancer].

Herszényi L, Farinati F, Plebani M, Carraro P, Roveroni G, De Paoli M, Cardin R, Naccarato R, Tulassay Z. Herszényi L, et al. Among authors: de paoli m. Orv Hetil. 1996 Jul 28;137(30):1637-41. Orv Hetil. 1996. PMID: 9019701 Review. Hungarian.

9

[The role of cathepsins and the plasminogen activator/inhibitor system in colorectal cancer].

Herszényi L, Farinati F, Plebani M, István G, Sápi Z, Carraro P, De Paoli M, Naccarato R, Tulassay Z. Herszényi L, et al. Among authors: de paoli m. Orv Hetil. 1999 Aug 15;140(33):1833-6. Orv Hetil. 1999. PMID: 10489782 Review. Hungarian.

10

The role of cysteine and serine proteases in colorectal carcinoma.

Herszènyi L, Plebani M, Carraro P, De Paoli M, Roveroni G, Cardin R, Tulassay Z, Naccarato R, Farinati F. Herszènyi L, et al. Among authors: de paoli m. Cancer. 1999 Oct 1;86(7):1135-42. doi: 10.1002/(sici)1097-0142(19991001)86:7<1135::aid-cncr6>3.0.co;2-2. Cancer. 1999. PMID: 10506696

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters